By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Discovery and development of novel therapies to treat diseases caused by protein dysregulation1.01M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States9.68M100.00%